Incyte Corp. (INCY)
106.21
+0.97
(+0.92%)
USD |
NASDAQ |
Jan 16, 16:00
106.50
+0.29
(+0.27%)
After-Hours: 20:00
Incyte Market Cap: 20.85B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 929.39B |
| Pfizer Inc. | 145.84B |
| Regeneron Pharmaceuticals, Inc. | 77.04B |
| Bio-Techne Corp. | 10.70B |
| Vertex Pharmaceuticals, Inc. | 111.98B |
Market Cap Related Metrics
| PE Ratio | 17.82 |
| PS Ratio | 4.390 |
| PEG Ratio | 0.0043 |
| Price to Book Value | 4.483 |
| Price to Free Cash Flow | 18.03 |
| Price | 106.21 |
| Earnings Yield | 5.61% |
| PEGY Ratio | 0.0043 |
| Operating PE Ratio | 16.82 |
| Normalized PE Ratio | 20.58 |